Cell/Tissue Microenvironment Engineering and Monitoring in Tissue Engineering, Regenerative Medicine, and In Vitro Tissue Models

    January 2014 in “ BioMed Research International
    Nihal Engin Vrana, Vasıf Hasirci, Garrett B. McGuinness, Albana Ndreu Halili
    New to Platelet-Rich Plasma? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This special issue reviews advancements in engineering cell microenvironments for tissue engineering, highlighting various studies on interventions like silk fibroin and platelet-rich plasma, but presents no new empirical findings.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document discusses the importance of understanding and controlling the cell microenvironment in tissue engineering and regenerative medicine. It highlights that as the fields have matured, knowledge about cell interactions with scaffolds and other cells has increased, emphasizing the significance of the cell microenvironment in controlling these interactions. The temporal nature of engineered tissues, which are remodeled over time, is also noted as a challenge, with current limitations in influencing this process for better regeneration. However, advancements in noninvasive monitoring methods and biosensor systems are providing tools for real-time information about engineered tissues. The special issue presented in the document showcases current developments and future perspectives in cell microenvironment engineering and monitoring, with contributions from various investigators. For instance, V. Cervelli et al. (2014) demonstrated the clinical application of bioactive agents in treating male pattern hair loss using platelet-rich plasma (PRP) injections, which resulted in a significant increase in hair density, epithelial thickness, and the number of hair follicles. The document concludes that engineering the cell microenvironment is crucial for future tissue engineering endeavors, including the development of organ-on-a-chip systems for pharmacological purposes.
    Discuss this study in the Community →